摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

没食子酸钠

中文名称
没食子酸钠
中文别名
——
英文名称
sodium gallate
英文别名
Sodium;5-carboxy-2,3-dihydroxyphenolate;sodium;5-carboxy-2,3-dihydroxyphenolate
没食子酸钠化学式
CAS
——
化学式
C7H5O5*Na
mdl
——
分子量
192.103
InChiKey
FZHLWVUAICIIPW-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3.83
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    101
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    没食子酸钠三甲基氯化锡乙醇 为溶剂, 以68%的产率得到Me3Sn(Gal)
    参考文献:
    名称:
    Design, spectral characterization, anti-tumor and anti-inflammatory activity of triorganotin(IV) hydroxycarboxylates, apoptosis inducers: In vitro assessment of induction of apoptosis by enzyme, DNA-fragmentation, acridine orange and comet assays
    摘要:
    Interaction of triorganotin(IV) chlorides with sodium salt of hydroxycarboxylic acids results in the formation of triorganotin(IV) hydroxycarboxylates, R3Sn(L) [R = Me, n-Bu and Ph; L = anion of glucuronic (HGlu), gallic (HGal) and mandelic (HMal) acid]. They exhibit trigonal-bipyramidal geometry which is well supported by elemental analysis, IR, H-1, C-13, Sn-119 NMR and ESI-MS spectral data. Triorganotin(IV) hydroxycarboxylates have been screened in vitro against five cancer cell lines of human origin viz. MCF-7, HEK-293, PC-3, HCT-15 and HepG-2. Title complexes are found to be cytotoxic to mildly cytotoxic, and exhibited IC50 values in the range 4-30 mu g/mL. The results of enzyme assays viz. glutathione reductase, glutathione peroxidase, total glutathione content and lipid peroxidase assay on MCF-7 cells indicate that the reactive oxygen species generated in the cancer cells by triorganotin(IV) hydroxycarboxylates is responsible for cell death. Marginal increase of lactate dehydrogenase suggests that necrosis is also occurring to a small extent. DNA (deoxyribonucleic acid) fragmentation assay, acridine orange assay and comet assay clearly support that the cell death is mainly due to apoptosis. The results obtained for the in vivo anti-inflammatory activity (% inhibition) and toxicity (LD50 in mg/kg) suggested that the complexes have low toxicity and good anti-inflammatory activity. (C) 2014 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ica.2014.02.034
  • 作为产物:
    描述:
    没食子酸sodium carbonate 作用下, 以 甲醇 为溶剂, 以98%的产率得到没食子酸钠
    参考文献:
    名称:
    Ru / II芳烃与生物活性羧酸盐配合物在水/ DMSO溶液中的合成,表征和行为
    摘要:
    将[RuCl(μ-Cl)的(η的反应6 - p -cymene)] 2与羧酸钠,在甲醇或乙腈溶液,得到复合物将[RuCl(κ 2 ö -RCO 2)(η 6 - p -cymene )](RCO 2  =丙戊酸盐,1;阿司匹林,2;双氯芬酸,3),收率79-96%。类似地,将[RuCl(κ 2 ö -dfCO 2)(η 6 -苯)],4,在混合副产物将[RuCl(μ-Cl)的(η获得具有轻微的6 -苯)] 2和双氯芬酸钠/银。将[RuCl(μ-Cl)的(η的连续反应6 - p -cymene)] 2与水杨酸钠和PPH 3得到的[Ru(κ 2 ö,O' -salCO 2)(PPH 3)(η 6 - p -cymene)],5,收率70%。的氢化物络合物的[Ru 2氯2(μ-Cl)的(μ-H)(η 6 - p -cymene)2 ],6,在从产率将[RuCl(μ-Cl)的(η36%制备6 - p
    DOI:
    10.1016/j.jorganchem.2018.05.020
点击查看最新优质反应信息

文献信息

  • Crystalline aluminosilicate zeolitic composition: UZM-15
    申请人:——
    公开号:US20040186337A1
    公开(公告)日:2004-09-23
    An aluminosilicate zeolite and substituted versions designated UZM-15 have been synthesized. These zeolites are prepared using an organo-ammonium cation as a template in which at least one organic group has at least 2 carbon atoms. An example of such a cation is diethyldimethyl-ammonium cation. The template can optionally comprise other organoammonium cations, alkali metals and alkaline earth metals. These UZM-15 materials can be dealuminated by various processes to provide UZM-15HS compositions. Both the UZM-15 and UZM-15HS compositions are useful as catalysts or catalyst supports in various process such as the conversion of cyclic hydrocarbons to non-cyclic hydrocarbons and olefin oligomerization.
    已合成一种含铝硅酸沸石及其取代版本,命名为UZM-15。这些沸石是使用有机阳离子作为模板制备的,其中至少有一个有机基含有至少2个碳原子。这种阳离子的一个例子是二乙基二甲基阳离子。模板可以选择性地包括其他有机阳离子、碱属和碱土属。这些UZM-15材料可以通过各种方法脱铝,得到UZM-15HS组成物。UZM-15和UZM-15HS组成物在各种过程中作为催化剂或催化剂载体是有用的,例如将环烃转化为非环烃和烯烃寡聚化。
  • Two-stage aromatics isomerization process
    申请人:Zhou Lubo
    公开号:US20070004947A1
    公开(公告)日:2007-01-04
    This invention is drawn to a process for isomerizing a non-equilibrium mixture of alkylaromatics in two sequential zones, the first zone operating in the absence of hydrogen using a platinum-free catalyst and the second zone using a catalyst comprising a molecular sieve and a platinum-group metal component to obtain improved yield of para-xylene from the mixture relative to prior art processes.
    该发明涉及一种过程,用于在两个连续的区域中异构化非平衡的烷基芳烃混合物,第一区域在没有氢气的情况下使用无催化剂运行,第二区域使用包含分子筛属组分的催化剂,以相对于先前工艺获得改善的对二甲苯产率。
  • Selective aromatics isomerization process
    申请人:Bauer E. John
    公开号:US20070004948A1
    公开(公告)日:2007-01-04
    A process for isomerizing xylenes while retaining ethylbenzene in a C 8 -aromatics stream in liquid phase uses a gallium-substituted pentasil zeolite in the absence of hydrogen.
    在液相中使用含的五硅酸沸石,在无氢气存在的情况下异构化二甲苯并保留乙基苯的C8芳烃流程。
  • [EN] METHOD OF WOUND HEALING<br/>[FR] PROCÉDÉ DE CICATRISATION
    申请人:CONNEXIOS LIFE SCIENCES PVT LTD
    公开号:WO2017025988A1
    公开(公告)日:2017-02-16
    The present invention relates to a method of treating a wound, comprising administering to a subject in need thereof a therapeutically effective amount of an aza adamantane compound according to Formula (I), or a pharmaceutically acceptable salt, thereof.
    本发明涉及一种治疗伤口的方法,包括向需要治疗的对象施用式(I)所示的含有治疗有效量的氮杂金刚烷化合物或其药学上可接受的盐。
  • COMPOSITION AND PROCESS FOR THE DISPLACEMENT OF HYDROGEN FROM WATER UNDER STANDARD TEMPERATURE AND PRESSURE CONDITIONS
    申请人:Parker John J.
    公开号:US20090280054A1
    公开(公告)日:2009-11-12
    The present invention relates to the production of hydrogen. More particularly, the present invention relates to a composition and process for the displacement of hydrogen from water under standard temperature and pressure conditions. The composition comprises finely divided metal powders (e.g., magnesium, or magnesium and aluminum) and can also contain a chloride salt (e.g., sodium chloride or potassium chloride). The process of the present invention comprises adding a composition of the present invention to water (either water that already contains chloride ions—such as seawater—or, alternatively, with compositions that contain a chloride salt, either fresh water or seawater), at standard temperature and pressure conditions, in order to create hydrogen gas from the displacement of hydrogen from the water.
    本发明涉及制氢。更具体地,本发明涉及一种在标准温度和压力条件下从中置换氢的组合物和方法。该组合物包括细分的属粉末(例如,或和铝),还可以含有化物盐(例如氯化钠氯化钾)。本发明的方法包括将本发明的组合物加入中(可以是已经含有氯离子,例如海,或者是含有化盐的组合物,无论是淡还是海),在标准温度和压力条件下,以从中置换氢的方式产生氢气
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫